The effect of L-dopa treatment on the speech of patients with Parkinson's disease.
D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D013060:Speech / Q000187:drug effects*; D013637:Tape Recording
D004295:Dihydroxyphenylalanine